Wellmarker Bio, a biotech startup spun off from Seoul Asan Medical Center specializes in developing patient-oriented anticancer drugs based on biomarkers. Biomarker is a biological indicator, such as protein, DNA, or RNA. It shows one’s health condition and allows us to predict the cause of one’s illness. Through biomarker, we can foresee the patient’s probability of getting diagnosed with incurable diseases or cancer and predicts whether the treatment can be efficacious before the administration. 

Link:https://www.edaily.co.kr/news/read?newsId=01439926622649640&mediaCodeNo=257&OutLnkChk=Y